Patents by Inventor Michele RETINI

Michele RETINI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrazole derivatives as phosphoinositide 3-kinases inhibitors
    Patent number: 10189844
    Abstract: Compounds of formula (I) defined herein are phosphoinositide 3-kinases (PI3K) inhibitors and are useful for the treatment of disorders associated with PI3K enzymes.
    Type: Grant
    Filed: January 31, 2017
    Date of Patent: January 29, 2019
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Matteo Biagetti, Anna Maria Capelli, Michele Retini
  • PYRAZOLE DERIVATIVES AS PHOSPHOINOSITIDE 3-KINASES INHIBITORS
    Publication number: 20170226109
    Abstract: Compounds of formula (I) defined herein are phosphoinositide 3-kinases (PI3K) inhibitors and are useful for the treatment of disorders associated with PI3K enzymes.
    Type: Application
    Filed: January 31, 2017
    Publication date: August 10, 2017
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Matteo BIAGETTI, Anna Maria CAPELLI, Michele RETINI
  • Indolizine derivatives as phoshoinositide 3-kinases inhibitors
    Patent number: 9527869
    Abstract: Compounds of formula (I), defined herein, inhibit phosphoinositide 3-kinases (PI3K) and are useful for the treatment of disorders associated with PI3K enzymes.
    Type: Grant
    Filed: June 17, 2015
    Date of Patent: December 27, 2016
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Matteo Biagetti, Alessandro Accetta, Anna Maria Capelli, Matilde Guala, Michele Retini
  • INDOLIZINE DERIVATIVES AS PHOSHOINOSITIDE 3-KINASES INHIBITORS
    Publication number: 20150361100
    Abstract: Compounds of formula (I), defined herein, inhibit phosphoinositide 3-kinases (PI3K) and are useful for the treatment of disorders associated with PI3K enzymes.
    Type: Application
    Filed: June 17, 2015
    Publication date: December 17, 2015
    Applicant: CHIESI FARMACEUTICI S.P.A.
    Inventors: Matteo BIAGETTI, Alessandro ACCETTA, Anna Maria CAPELLI, Matilde GUALA, Michele RETINI